The microbiome of dental and peri-implant subgingival plaque during peri-implant mucositis therapy: A randomized clinical trial

Juliana Philip, Mark J. Buijs, Vincent Y. Pappalardo, Wim Crielaard, Bernd W. Brandt, Egija Zaura*

*Corresponding author for this work

Research output: Contribution to JournalArticleAcademicpeer-review

Abstract

Aim: To assess the microbial effects of mechanical debridement in conjunction with a mouthrinse on sites with peri-implant mucositis and gingivitis. Materials and methods: Eighty-nine patients with peri-implant mucositis were included in a double-blinded, randomized, placebo-controlled trial with mechanical debridement and 1-month use of either delmopinol, chlorhexidine (CHX), or a placebo mouthrinse. Submucosal and subgingival plaque samples of implants and teeth were collected at baseline and after 1 and 3 months, processed for 16S V4 rRNA gene amplicon sequencing, and analysed bioinformatically. Results: The sites with peri-implant mucositis presented with a less diverse and less anaerobic microbiome. Exposure to delmopinol or CHX, but not to the placebo mouthrinse resulted in microbial changes after 1 month. The healthy sites around the teeth harboured a more diverse and more anaerobe-rich microbiome than the healthy sites around the implants. Conclusions: Peri-implant sites with mucositis harbour ecologically less complex and less anaerobic biofilms with lower biomass than patient-matched dental sites with gingivitis while eliciting an equal inflammatory response. Adjunctive antimicrobial therapy in addition to mechanical debridement does affect both dental and peri-implant biofilm composition in the short term, resulting in a less dysbiotic subgingival biofilm.

Original languageEnglish
Pages (from-to)28-38
Number of pages11
JournalJournal of Clinical Periodontology
Volume49
Issue number1
Early online date19 Oct 2021
DOIs
Publication statusPublished - Jan 2022

Bibliographical note

Funding Information:
We thank the participants of the clinical study, the AUMC Cancer Center Amsterdam (Amsterdam, the Netherlands) for sequencing the amplicon on the Illumina Miseq system, and Elly van Deutekom and Wendy de Wit for their contribution in sample preparation for sequencing.

Funding Information:
The work presented here was funded by the Department of Preventive Dentistry, Academic Center for Dentistry Amsterdam, The Netherlands. Funding information

Publisher Copyright:
© 2021 The Authors. Journal of Clinical Periodontology published by John Wiley & Sons Ltd.

Funding

We thank the participants of the clinical study, the AUMC Cancer Center Amsterdam (Amsterdam, the Netherlands) for sequencing the amplicon on the Illumina Miseq system, and Elly van Deutekom and Wendy de Wit for their contribution in sample preparation for sequencing. The work presented here was funded by the Department of Preventive Dentistry, Academic Center for Dentistry Amsterdam, The Netherlands. Funding information

Keywords

  • chlorhexidine
  • delmopinol
  • dental implant
  • microbiome
  • peri-implant mucositis
  • subgingival plaque
  • submucosal plaque

Fingerprint

Dive into the research topics of 'The microbiome of dental and peri-implant subgingival plaque during peri-implant mucositis therapy: A randomized clinical trial'. Together they form a unique fingerprint.

Cite this